Redox regulation of metabolic and signaling pathways by thioredoxin and glutaredoxin in NOS-3 overexpressing hepatoblastoma cells

Redox Biology

Volumn 6, Issue , 2015, Pages 122-134

  González, Raúl ^a,b   López Grueso, M José ^a   Muntané, Jordi ^c,d   Bárcena, J Antonio ^a,b   Padilla, C Alicia ^a,b  

^a UNIVERSITY OF CÓRDOBA   (Spain)

^b Instituto de Salud Carlos III   (Spain)

^c HOSPITAL UNIVERSITARIO VIRGEN DEL ROCÍO   (Spain)

^d INSTITUTO DE SALUD CARLOS III   (Spain)

Author keywords

Apoptosis; Cancer; Glutaredoxin; Oxidative nitrosative stress; Thioredoxin

Indexed keywords

CASPASE 3; CASPASE 8; ENDOTHELIAL NITRIC OXIDE SYNTHASE; GLUTAREDOXIN; MITOGEN ACTIVATED PROTEIN KINASE; NITRIC OXIDE SYNTHASE; NUCLEOTIDE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; THIOREDOXIN; AKT1 PROTEIN, HUMAN; CASP3 PROTEIN, HUMAN; CASP8 PROTEIN, HUMAN; CYSTEINE; FAS ANTIGEN; FAS PROTEIN, HUMAN; GLRX PROTEIN, HUMAN; NICOTINAMIDE ADENINE DINUCLEOTIDE PHOSPHATE; NITRIC OXIDE; NOS3 PROTEIN, HUMAN; PROTEIN KINASE B; SMALL INTERFERING RNA; TXN PROTEIN, HUMAN;

ANTIPROLIFERATIVE ACTIVITY; APOPTOSIS; ARTICLE; CELL PROLIFERATION; CONTROLLED STUDY; ENVIRONMENTAL FACTOR; ENZYME ACTIVITY; HEPATOBLASTOMA; HUMAN; HUMAN CELL; NITROSYLATION; NUCLEOTIDE METABOLISM; OXIDATION REDUCTION STATE; PENTOSE PHOSPHATE CYCLE; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; ANTAGONISTS AND INHIBITORS; CELL SURVIVAL; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; HEP-G2 CELL LINE; METABOLISM; OXIDATION REDUCTION REACTION; PHOSPHORYLATION;

ANTIGENS, CD95; CASPASE 3; CASPASE 8; CELL PROLIFERATION; CELL SURVIVAL; CYSTEINE; GENE EXPRESSION REGULATION, NEOPLASTIC; GLUTAREDOXINS; HEP G2 CELLS; HUMANS; NADP; NITRIC OXIDE; NITRIC OXIDE SYNTHASE TYPE III; OXIDATION-REDUCTION; PHOSPHORYLATION; PROTO-ONCOGENE PROTEINS C-AKT; RNA, SMALL INTERFERING; SIGNAL TRANSDUCTION; THIOREDOXINS;

EID: 84937778893     PISSN: 22132317     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.redox.2015.07.007     Document Type: Article

References (61)

1. Muntané J., la Mata M. Nitric oxide and cancer. World J. Hepatol. 2010, 2:337-344.
2. Alderton W., Cooper C., Knowles R. Nitric oxide synthases: structure, function and inhibition. Biochem. J. 2001, 357:593-615.
3. Geller D.A., Billiar T.R. Molecular biology of nitric oxide synthases. Cancer Metastasis Rev. 1998, 17:7-23.
4. Forstermann U., Boissel J.P., Kleinert H. Expressional control of the 'constitutive' isoforms of nitric oxide synthase (NOS I and NOS III). FASEB J. 1998, 12:773-790.
5. Bredt D., Hwang P., CE.G., Lowenstein C., Reed R., Snyder S. Cloned and expressed nitric oxide synthase structurally resembles cytochrome P-450 reductase. Nature 1991, 351:714-718.
6. Lamas S., Marsden P., Li G., Tempst P., Michel T. Endothelial nitric oxide synthase: molecular cloning and characterization of a distinct constitutive enzyme isoform. Proc. Natl. Acad. Sci. USA 1992, 89:6348-6352.
7. Lyons C., Orloff G., Cunningham J. Molecular cloning and functional expression of an inducible nitric oxide synthase from a murine macrophage cell line. J. Biol. Chem. 1992, 267:6370-6374.
8. Xie Q., Cho H., Calaycay J., Mumford R., Swiderek K., Lee T., Ding A., Troso T., Nathan C. Cloning and characterization of inducible nitric oxide synthase from mouse macrophages. Science 1992, 256:225-228.
9. Xu W., Liu L., Loizidou M., Ahmed M., Charles I. The role of nitric oxide in cancer. Cell Res. 2002, 12:311-320.
10. Boo Y., Kim H., Song H., Fulton D., Sessa W., Jo H. Coordinated regulation of endothelial nitric oxide synthase activity by phosphorylation and subcellular localization. Free Radic. Biol. Med. 2006, 41:144-153.
11. Oess S., Icking A., Fulton D., Govers R., Müller-Esterl W. Subcellular targeting and trafficking of nitric oxide synthases. Biochem. J. 2006, 396:401-409.
12. Iwakiri Y., Satoh A., Chatterjee S., Toomre D., Chalouni C., Fulton D., Groszmann R., Shah V., Sessa W. Nitric oxide synthase generates nitric oxide locally to regulate compartmentalized protein S-nitrosylation and protein trafficking. Proc. Natl. Acad. Sci. USA 2006, 103:19777-19782.
13. Li C., Woga G. Nitric oxide as a modulator of apoptosis. Cancer Lett. 2005, 226:1-15.
14. Li H., Wan A. Apoptosis of rheumatoid arthritis fibroblast-like synoviocytes: possible roles of nitric oxide and the thioredoxin 1. Mediat. Inflamm. 2013, 2013:1-8.
15. Buchanan B., Balmer Y. Redox regulation: a broadening horizon. Annu. Rev. Plant Biol. 2005, 56:187-220.
16. Burgoyne J., Madhani M., Cuello F., Charles R., Brennan J., Schröder E., Browning D., Eaton P. Cysteine redox sensor in PKGI(alfa) enables oxidant-induced activation. Science 2007, 317:1393-1397.
17. Ghezzi P., Bonetto V., Fratelli M. Thiol-disulfide balance: from the concept of oxidative stress to that of redox regulation. Antioxid. Redox Signal. 2005, 7:964-972.
18. Martinez-Ruiz A., Cadenas S., Lamas S. Nitric oxide signaling: classical, less classical, and nonclassical mechanisms. Free Radic. Biol. Med. 2011, 51:17-29.
19. Hess D., Matsumoto A., Kim S., Marshall H., Stamler J. Protein S-nitrosylation: purview and parameter. Nat. Rev. Mol. Cell. Biol. 2005, 6:150-166.
20. Derakhshan B., Hao G., Gross S. Balancing reactivity against selectivity: the evolution of protein S-nitrosylation as an effector of cell signaling by nitric oxide. Cardiovasc. Res. 2007, 75:210-219.
21. Foster M., McMahon T., Stamler J. S-nitrosylation in health and disease. Trends Mol. Med. 2003, 9:160-168.
22. Nakamura H., Nakamura K., Yodoi J. Redox regulation of cellular activation. Annu. Rev. Immunol. 1997, 15:351-369.
23. Holmgren A. Thioredoxin and glutaredoxin systems. J. Biol. Chem. 1989, 264:13963-13966.
24. Holmgren A., Johansson C., Berndt C., Lönn M., Lillig C. Thiol redox control via thioredoxin and glutaredoxin systems. Biochem. Soc. Trans. 2005, 33:1375-1377.
25. Padilla C., Martínez-Galisteo E., Bárcena J., Spyrou G., Holmgren A. Purification from placenta, amino acid sequence, structure comparisons and cDNA cloning of human glutaredoxin. Eur. J. Biochem. 1995, 227:27-34.
26. Gallogly M., Mieyal J. Mechanisms of reversible protein glutathionylation in redox signaling and oxidative stress. Curr. Opin. Pharmacol. 2007, 7:381-391.
27. Benhar M., Forrester M., Stamler J. Regulated protein denitrosylation by cytosolic and mitochondrial thioredoxins. Science 2008, 320:1050-1054.
28. Sengupta R., Billiar T., Kagan V., Stoyanovsky D. Nitric oxide and thioredoxin type 1 modulate the activity of caspase 8 in HepG2 cells. Biochem. Biophys. Res. Commun. 2010, 391:1127-1130.
29. Mitchell D., Marletta M. Thioredoxin catalyzes the S-nitrosation of the caspase-3 active site cysteine. Nat. Chem. Biol. 2005, 1:154-158.
30. Du Y., Zhang H., Lu J., Holmgren A. Glutathione and glutaredoxin act as a backup of human thioredoxin reductase 1 to reduce thioredoxin 1 preventing cell death by aurothioglucose. J. Biol. Chem. 2012, 287:38210-38219.
31. Arner E., Holmgren A. The thioredoxin system in cancer. Semin. Cancer Biol. 2006, 16:420-426.
32. Saitoh M., Nishitoh H., Fujii M., Takeda K., Tobiume K., Sawada Y., Kawabata M., Miyazono K., Ichijo H. Mammalian thioredoxin is a direct inhibitor of apoptosis signal-regulating kinase (ASK) 1. EMBO J. 1998, 17:2596-2606.
33. Li H., Wan A., Xu G., Ye D. Small changes huge impact: the role of thioredoxin 1 in the regulation of apoptosis by S-nitrosylation. Acta Biochim. Biophys. Sin. 2013, 45:153-161.
34. Greetham D., Kritsiligkou P., Watkins R., Carter Z., Parkin J., Grant C. Oxidation of the yeast mitochondrial thioredoxin promotes cell death. Antioxid. Redox Signal. 2013, 18:376-385.
35. Ahmad F., Nidadavolu P., Durgadoss L., Ravindranath V. Critical cysteines in Akt1 regulate its activity and proteasomal degradation: implications for neurodegenerative diseases. Free Radic. Biol. Med. 2014, 74:118-128.
36. Enoksson M., Fernandes A., Prast S., Lillig C., Holmgren A., Orrenius S. Overexpression of glutaredoxin 2 attenuates apoptosis by preventing cytochrome c release. Biochem. Biophys. Res. Commun. 2005, 327:774-779.
37. González R., Ferrín G., Aguilar-Melero P., Ranchal I., Linares C., Bello R., De la Mata M., Gogvadze V., Bárcena J., Álamo J., Orrenius S., Padillo F., Zhivotovsky B., Muntané J. Targeting hepatoma using nitric oxide donor strategies. Antioxid. Redox Signal. 2013, 18:491-506.
38. López-Sánchez L., Corrales F., De la Mata M., Muntané J., Rodríguez-Ariza A. Detection and proteomic identification of S-nitrosated proteins in human hepatocytes. Methods Enzymol. 2008, 440:273-281.
39. Harris I., Treloar A., Inoue S., Sasaki M., Gorrini C., Lee K., Yung K., Brenner D., Knobbe-Thomsen C., Cox M., Elia A., Berger T., Cescon D., Adeoye A., Brüstle A., Molyneux S., Mason J., Li W., Yamamoto K., Wakeham A., Berman H., Khokha R., Done S., Kavanagh T., Lam C., Mak T. Glutathione and thioredoxin antioxidant pathways synergize to drive cancer initiation and progression. Cancer Cell 2015, 27:211-222.
40. Watson J. Oxidants, antioxidants and the current incurability of metastatic cancers. Open Biol. 2013, 3:1-9.
41. Luthman M., Holmgren A. Glutaredoxin from calf thymus. Purification to homogeneity. J. Biol. Chem. 1982, 257:6686-6690.
42. Holmgren A. Thioredoxin catalyzes the reduction of insulin disulfides by dithiothreitol and dihydrolipoamide. J. Biol. Chem. 1979, 254:9627-9632.
43. Yang L., Wu D., Wang X., Cederbaum A. Depletion of cytosolic or mitochondrial thioredoxin increases CYP2E1-induced oxidative stress via an ASK-1-JNK1 pathway in HepG2 cells. Free Radic. Biol. Med. 2011, 51:185-196.
44. Trachootham D., Lu W., Ogasawara M., Rivera-Del Valle N., Huang P. Redox regulation of cell survival. Antioxid. Redox Signal. 2008, 10:1343-1374.
45. Radi R. Nitric oxide, oxidants, and protein tyrosine nitration. Proc. Natl. Acad. Sci. USA 2004, 101:4003-4008.
46. Anastasiou D., Poulogiannis G., Asara J., Boxer M., Jiang J., Shen M., Bellinger G., Sasaki A., Locasale J., Auld D., Thomas C., Vander Heiden M., Cantley L. Inhibition of pyruvate kinase M2 by reactive oxygen species contributes to cellular antioxidant responses. Science 2011, 334:1278-1283.
47. Ito E., Yue S., Moriyama E., Hui A., Kim I., Shi W., Alajez N., Bhogal N., Li G., Datti A., Schimmer A., Wilson B., Liu P., Durocher D., Neel B., O'Sullivan B., Cummings B., Bristow R., Wrana J., Liu F.-F. Uroporphyrinogen decarboxylase is a radiosensitizing target for head and neck cancer. Sci. Transl. Med. 2011, 3:1-7.
48. McDonagh B., Pedrajas J., Padilla C., Barcena J. Thiol redox sensitivity of two key enzymes of heme biosynthesis and pentose phosphate pathways: uroporphyrinogen decarboxylase and transketolase. Oxid. Med. Cell. Longev. 2013, 1-13. (ID 932472).
49. Pajares M., Markham G. Methionine adenosyltransferase (s-adenosylmethionine synthetase). Adv. Enzymol. Relat. Areas Mol. Biol. 2011, 78:449-521.
50. Murata H., Ihara Y., Nakamura H., Yodoi J., Sumikawa K., Kondo T. Glutaredoxin exerts an antiapoptotic effect by regulating the redox state of Akt. J. Biol. Chem. 2003, 278:50226-50233.
51. Song J., Lee Y. Differential role of glutaredoxin and thioredoxin in metabolic oxidative stress-induced activation of apoptosis signal-regulating kinase 1. Biochem. J. 2003, 373:845-853.
52. Xie Y., Kole s, Precht P., Pazin M., Bernier M. S-glutathionylation impairs signal transducer and activator of transcription 3 activation and signaling. Endocrinology 2009, 150:1122-1131.
53. Ogata F., Batista W., Sartori A., Gesteira T., Masutani H., Arai R., Yodoi J., Stern A., Monteiro H. Nitrosative/oxidative stress conditions regulate thioredoxin-interacting protein (TXNIP) expression and thioredoxin-1 (TRX-1) nuclear localization. PLoS One 2013, 8:e84588.
54. Ischiropoulos H. Biological selectivity and functional aspects of protein tyrosine nitration. Biochem. Biophys. Res. Commun. 2003, 305:776-783.
55. Haqqani A., Kelly J., Birnboim H. Selective nitration of histone tyrosine residues in vivo in mutatect tumors. J. Biol. Chem. 2002, 277:3614-3621.
56. Kamisaki Y., Wada K., Bian K., Balabanli B., Davis K., Martin E., Behbod F., Lee Y.-C., Murad F. An activity in rat tissues that modifies nitrotyrosine-containing proteins. Proc. Natl. Acad. Sci. USA 1998, 95:11584-11589.
57. Radi R. Protein tyrosine nitration: biochemical mechanisms and structural basis of its functional effects. Acc. Chem. Res. 2013, 46:550-559.
58. Sengupta R., Holmgren A. The role of thioredoxin in the regulation of cellular processes by S-nitrosylation. Biochim. Biophys. Acta 2012, 1820:689-700.
59. Hashemy S., Holmgren A. Regulation of the catalytic activity and structure of human thioredoxin 1 via oxidation and S-nitrosylation of cysteine residues. J. Biol. Chem. 2008, 283:21890-21898.
60. Haendeler J., Hoffmann J., Tischler V., Berk B., Zeiher A., Dimmeler S. Redox regulatory and anti-apoptotic functions of thioredoxin depend on S-nitrosylation at cysteine 69. Nat. Cell Biol. 2002, 4:743-749.
61. Barglowa K., Knutsonb C., Wishnokb J., Tannenbaumb S., Marletta M. Site-specific and redox-controlled S-nitrosation of thioredoxin. Proc. Natl. Acad. Sci. USA 2011, 108:600-606.